Gardner-based New England Peptide LLC has opened a 1,000-square-foot addition to its production facility.
The expansion is part of NEP’s effort to enter the worldwide market for clinical and commercial-grade peptides. The company said demand for its custom peptides and antibodies has been on the rise.
NEP’s products have applications in the biotechnology and pharmaceutical industries.
